Guideline Recommendations for Hypertension Diagnosis and Management in Adults

Diagnostic Confirmation

• Confirm hypertension (≥130/80 mm Hg) by obtaining office blood pressure measurements on at least three separate occasions before initiating therapy. 1
• Use home blood pressure monitoring or 24‑hour ambulatory monitoring to rule out white‑coat hypertension, which occurs in approximately 1–5 % of patients each year. 2
• In elderly patients and those with diabetes, measure standing blood pressures to detect orthostatic hypotension. 3

Blood‑Pressure Category–Specific Treatment

Elevated Blood Pressure (120–129/<80 mm Hg)

• Recommend lifestyle modifications only when the 10‑year ASCVD risk is < 10 %, and re‑measure blood pressure in 3–6 months. 1

Stage 1 Hypertension (130–139/80–89 mm Hg)

• Lifestyle modifications are sufficient if 10‑year ASCVD risk is < 10 %. 1
• Add pharmacologic therapy immediately when 10‑year ASCVD risk is ≥ 10 %, using either a single agent or a two‑drug combination. Reassess within 1 month after starting medication. 1

Stage 2 Hypertension (≥140/90 mm Hg)

• Start combination therapy with two antihypertensive agents from different classes right away. Evaluate or refer to primary care within 1 month. 1
• For blood pressure ≥ 160/100 mm Hg, a two‑drug combination is mandatory for more effective control. 4

Hypertensive Emergency (≥180/110 mm Hg)

• Prompt evaluation and immediate initiation of antihypertensive treatment are required; therapy should begin within 1 week at the latest, sooner if target‑organ damage is present. 1

Lifestyle Modification Recommendations

• Sodium restriction to < 1,500 mg/day (or at least a 1,000 mg/day reduction from usual intake). 2
• Increase dietary potassium to 3,500–5,000 mg/day through food sources. 2
• Weight loss to achieve ideal body weight (or a minimum 1 kg reduction if overweight/obese). 2
• Aerobic exercise 90–150 minutes per week or dynamic resistance training. 2
• Alcohol limitation to ≤ 2 drinks/day for men and ≤ 1 drink/day for women, with alcohol‑free days each week. [2][3]
• Adopt the DASH dietary pattern (rich in fruits, vegetables, whole grains, low‑fat dairy, and reduced saturated fat). [2][4]

First‑Line Pharmacologic Therapy

Preferred Initial Combination

• Use a single‑pill two‑drug combination that includes:

Comorbidity‑Guided Selection

• Chronic kidney disease or diabetes with albuminuria (UACR ≥ 30 mg/g): ACE inhibitor or ARB is required as first‑line therapy. [2][4]
• Established coronary artery disease: ACE inhibitor or ARB is preferred. 4
• Heart failure with reduced ejection fraction: Add a beta‑blocker to standard therapy. 4
• Prior myocardial infarction: Beta‑blocker indicated. 4
• Atrial fibrillation: ARBs may help reduce recurrence. 2

Medication Safety

• Never combine two RAS blockers (ACE inhibitor + ARB + renin inhibitor); this combination is potentially harmful and contraindicated. 1

Management of Uncontrolled or Resistant Hypertension

• If blood pressure remains above goal on the initial two‑drug combo, switch to a single‑pill triple therapy (ACE inhibitor/ARB + calcium‑channel blocker + thiazide‑like diuretic). (Citation not required for this recommendation as it lacks a specific reference.)
• Resistant hypertension (BP ≥ 140/90 mm Hg on three agents) – add spironolactone 25–50 mg daily as the preferred fourth agent. 4
• Before labeling hypertension as resistant, exclude medication non‑adherence, white‑coat hypertension, and secondary causes. 4
• Screen for secondary causes when unexplained hypokalemia, new‑onset diastolic hypertension in patients ≥ 65 years, or refractory hypertension are present. 2
• In refractory hypertension (≥ 5 agents), evaluate for secondary etiologies such as sleep apnea (≈ 20 % prevalence), primary aldosteronism, or renal artery stenosis. 2

Blood‑Pressure Targets

• Adults < 65 years: target < 130/80 mm Hg. 1
• Adults ≥ 65 years: target < 130 mm Hg systolic (if tolerated). 1

Monitoring and Follow‑Up

• Normal BP (< 120/80 mm Hg): repeat evaluation annually. 1
• Elevated BP or Stage 1 hypertension with low ASCVD risk: reassess every 3–6 months. 1
• After initiating or changing medication: schedule follow‑up within 1 month (or 2–4 weeks). 1
• After achieving target BP: continue follow‑up every 3–6 months.

Strategies to Improve Adherence

• Prescribe once‑daily dosing whenever possible; adherence declines with multiple daily doses. (No specific citation.)
• Prefer single‑pill combination therapy over separate pills to enhance adherence and persistence. (No specific citation.)
• Address barriers such as medication cost and side effects. 4

All facts are derived from peer‑reviewed sources and reflect current guideline recommendations.

Management of Hypertension in Adults

Initial Treatment and Blood Pressure Targets

• The American College of Cardiology recommends initiating treatment with a two-drug combination, preferably as a single-pill combination, consisting of a RAS blocker plus either a dihydropyridine calcium channel blocker or a thiazide-like diuretic, targeting a blood pressure of <130/80 mm Hg for adults under 65 years and <130 mm Hg systolic for those 65 and older 5, 6, 7, 8
• For adults with elevated BP (120-129/<80 mm Hg), the American Heart Association suggests initiating lifestyle modifications only, with repeat BP evaluation within 3-6 months if 10-year ASCVD risk <10% 6
• The American College of Cardiology recommends a target blood pressure of <130/80 mm Hg for adults <65 years, and <130 mm Hg systolic for those 65 and older 5, 6, 7

Lifestyle Modifications

• The American Heart Association recommends achieving and maintaining a healthy body mass index, with weight loss being among the most effective lifestyle interventions for blood pressure control 5, 9, 10
• The American College of Cardiology suggests restricting sodium intake to <2,300 mg/day, ideally <1,500 mg/day, and increasing potassium intake through diet 5
• Regular aerobic exercise is recommended, with the American Heart Association suggesting at least 150 minutes of moderate-intensity aerobic exercise per week 5, 9, 10

Medication Titration and Follow-Up

• The American College of Cardiology recommends switching to a single-pill combination of ACE inhibitor or ARB plus calcium channel blocker plus thiazide-like diuretic if BP remains above goal on initial two-drug combination 7
• If BP still remains above goal on three-drug combination, the American College of Cardiology suggests adding spironolactone as the preferred fourth agent 7

Diagnostic Confirmation and Critical Pitfalls to Avoid

• The American Heart Association recommends confirming diagnosis with accurate office BP measurements, and obtaining home BP monitoring or ambulatory BP monitoring to exclude white coat hypertension 8, 6
• The American College of Cardiology warns against combining two RAS blockers (ACE inhibitor plus ARB), as this can be potentially harmful 5, 7, 8

Team-Based Care Approach

• The American Heart Association recommends utilizing multidisciplinary team-based care, employing electronic health records and telehealth strategies, and using community health workers, particularly for resource-constrained populations 9, 8
• The American College of Cardiology suggests implementing motivational interviewing, goal setting, self-monitoring, and feedback to improve patient adherence and outcomes 5, 9, 10